<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We tested whether carotid artery intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) is associated with plasma cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> transfer (<z:chebi fb="33" ids="124991">CET</z:chebi>) and/or the plasma cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> transfer protein (CETP) concentration in type 2 diabetic and control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>In 87 male and female subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (nonsmokers, no insulin or <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering drug treatment) and 82 control subjects, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, plasma <z:chebi fb="33" ids="124991">CET</z:chebi>, CETP mass, and <z:chebi fb="23" ids="18059">lipids</z:chebi> were determined </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> was lower, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, pulse pressure, plasma <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, and plasma <z:chebi fb="33" ids="124991">CET</z:chebi> and CETP concentration were higher in diabetic patients versus control subjects </plain></SENT>
<SENT sid="3" pm="."><plain>In diabetic patients, plasma <z:chebi fb="33" ids="124991">CET</z:chebi> was positively determined by <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (P &lt; 0.001), non-<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (P &lt; 0.001), CETP (P = 0.002), and the interaction between CETP and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (P = 0.004) </plain></SENT>
<SENT sid="4" pm="."><plain>In control subjects, plasma <z:chebi fb="33" ids="124991">CET</z:chebi> was positively related to <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (P &lt; 0.001) and non-<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> was inversely related to plasma <z:chebi fb="33" ids="124991">CET</z:chebi> in each group (P &lt; 0.01 for both) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was positively associated with plasma <z:chebi fb="33" ids="124991">CET</z:chebi> in diabetic (P = 0.05) and control (P &lt; 0.05) subjects after adjustment for age, sex, and pulse pressure </plain></SENT>
<SENT sid="7" pm="."><plain>No independent relationship with plasma CETP mass was found </plain></SENT>
<SENT sid="8" pm="."><plain>Plasma <z:chebi fb="33" ids="124991">CET</z:chebi> is a positive determinant of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Plasma CETP mass, in turn, is a determinant of <z:chebi fb="33" ids="124991">CET</z:chebi> with an increasing effect at higher <z:chebi fb="4" ids="17855">triglycerides</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>These data, therefore, provide a rationale to evaluate the effects of <z:chebi fb="0" ids="49205">CETP inhibitor</z:chebi> treatment on plasma <z:chebi fb="33" ids="124991">CET</z:chebi> and on cardiovascular risk in <z:mp ids='MP_0002055'>diabetes</z:mp>-associated <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> </plain></SENT>
</text></document>